Inborn Errors of Immunity
Open Access
- 11 April 2024
- book chapter
- Published by Springer Nature
- p. 809-817
Abstract
Inborn errors of immunity (IEI) comprise diseases arising from genetic defects that lead to abnormalities in immune cell development or function with a wide spectrum in severity and clinical manifestations. The number of transplants for IEI has increased significantly over the last years, elicited by better insight in the pathogenesis of the IEI (and thus the “curability” of these diseases with allo-HCT), better outcomes even with unrelated and haploidentical donors, and more differentiated approaches to HCT including reduced toxicity conditioning regimens.Keywords
This publication has 48 references indexed in Scilit:
- Prospective Newborn Screening for SCID in Germany: A First Analysis by the Pediatric Immunology Working Group (API)Journal of Clinical Immunology, 2023
- The 2022 Update of IUIS Phenotypical Classification for Human Inborn Errors of ImmunityJournal of Clinical Immunology, 2022
- Haploidentical Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide for Primary Immunodeficiencies and Inherited Disorders in ChildrenTransplantation and Cellular Therapy, 2019
- Treosulfan and Fludarabine Conditioning for Hematopoietic Stem Cell Transplantation in Children with Primary Immunodeficiency: UK ExperienceTransplantation and Cellular Therapy, 2018
- From clinical observations and molecular dissection to novel therapeutic strategies for primary immunodeficiency disordersAmerican Journal of Medical Genetics Part A, 2017
- Single-Center Experience of Unrelated and Haploidentical Stem Cell Transplantation with TCRαβ and CD19 Depletion in Children with Primary Immunodeficiency SyndromesTransplantation and Cellular Therapy, 2015
- Newborn Screening for Severe Combined Immunodeficiency in 11 Screening Programs in the United StatesJAMA, 2014
- Health Related Quality of Life and Emotional Health in Children with Chronic Granulomatous Disease: A Comparison of Those Managed Conservatively with Those That Have Undergone Haematopoietic Stem Cell TransplantJournal of Clinical Immunology, 2012
- Long-term efficacy of enzyme replacement therapy for Adenosine deaminase (ADA)-deficient Severe Combined Immunodeficiency (SCID)Clinical Immunology, 2005
- European experience of bone-marrow transplantation for severe combined immunodeficiencyThe Lancet, 1990